Semaglutide - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
Product details |
Supply Impact Dates |
Further Details |
OZEMPIC 0.25 mg/0.5mg semaglutide (rys) 0.68 mg/mL solution for injection in 3mL pre-filled pen AUST R: 446290Active ingredients:
Semaglutide
Dosage form: Injection, solution
Sponsor: Novo Nordisk Pharmaceuticals Pty Ltd
Phone: 1800668626
|
From 01 Jun 2025 to 31 Dec 2025
|
Shortage status: Current
Availability: Limited Availability
Reason: Unexpected increase in consumer demand
Management action: This product replaces ARTG 308324 OZEMPIC 0.25/0.5 mg semaglutide (rys) 1.34 mg/mL solution for injection pre-filled pen which has been discontinued. More information about this supply change is available from https://www.tga.gov.au/safety/shortages/medicine-shortage-alerts/new-presentation-ozempic-semaglutide-025-mg05-mg-pre-filled-pens. An unregistered product has been approved for supply under Section 19A. The approval holder, Medsurge Healthcare Pty Ltd, can be contacted for details on supply on 1300 788 261.
|
OZEMPIC 1 mg semaglutide (rys) 1.34 mg/mL solution for injection pre-filled pen AUST R: 315107Active ingredients:
Semaglutide
Dosage form: Injection, solution
Sponsor: Novo Nordisk Pharmaceuticals Pty Ltd
Phone: 1800668626
|
From 15 Apr 2022 to 31 Dec 2025
|
Shortage status: Current
Availability: Limited Availability
Reason: Unexpected increase in consumer demand
Management action: An unregistered product has been approved for supply under Section 19A. The approval holder, Medsurge Healthcare Pty Ltd, can be contacted for details on supply on 1300 788 261. A TGA web statement is available at https://www.tga.gov.au/safety/shortages/medicine-shortage-alerts/update-ozempic-supply-remain-limited-2025.
|
OZEMPIC 0.25/0.5 mg semaglutide (rys) 1.34 mg/mL solution for injection pre-filled pen AUST R: 308324Active ingredients:
Semaglutide
Dosage form: Injection, solution
Sponsor: Novo Nordisk Pharmaceuticals Pty Ltd
Phone: 1800668626
|
Deletion from market:
01 Dec 2025
|
Shortage status: To be discontinued
Availability: Reduction in supply until supply is exhausted
Reason: Commercial Changes / Commercial viability
Management action: This product will be replaced by ARTG 446290 OZEMPIC 0.25 mg/0.5mg semaglutide (rys) 0.68 mg/mL solution for injection in 3mL pre-filled pen. More information about this supply change is available from https://www.tga.gov.au/safety/shortages/medicine-shortage-alerts/new-presentation-ozempic-semaglutide-025-mg05-mg-pre-filled-pens. An unregistered product has been approved for supply under Section 19A. The approval holder, Medsurge Healthcare Pty Ltd, can be contacted for details on supply on 1300 788 261.
|